YouTube

ARTICLE | Distillery Therapeutics

Dual activation of JNK1 and JNK2 for STK11-deficient lung cancer

Hongjiang Li

May 28, 2019 5:48 PM UTC

INDICATION: Lung cancer ...

Get Unlimited Access

Continue reading with a free trial.

Start a Free Trial Log In

Or Purchase This Article

BCIQ Company Profiles

National Institute of Environmental Health Sciences

BCIQ Target Profiles

Serine/threonine kinase 11 (STK11) (LKB1)

c-jun N-terminal kinase 1 (JNK1) (MAPK8)

c-jun N-terminal kinase 2 (JNK2) (MAPK9)

BCIQ Company Profiles

National Institute of Environmental Health Sciences

BCIQ Target Profiles

Serine/threonine kinase 11 (STK11) (LKB1)

c-jun N-terminal kinase 1 (JNK1) (MAPK8)

c-jun N-terminal kinase 2 (JNK2) (MAPK9)